OUTRUN THERAPEUTICS LIMITED

🏛️Establishedactive

SC648164 · ltd · incorporated 2019-11-26

Investment thesis

Established operating company — standard diligence applies, no dominant angle.

Why interesting: Live, filing, normal profile.

Why risky: No standout signals in either direction.

🔒Estimated value

—

Upgrade to see

Turnover

—

year to Dec 2024

Net worth

—

book net assets

Opportunity

76/100

Strong

🔒Generate AI memo →🔒Outreach pack →🔒Corporate story →📑 Reports →Sign in to watch

What this business does

Primary activity: Other human health activities

Sector: Human health & social work

Investor take

Pursue

Strong opportunity: active trading company with strong profile and bankable structure.

Opportunity 76/100 (strong), bankability 75/100. Share purchase looks the cleaner deal structure. Most likely exit: strategic trade sale (73/100).

Data confidence

Overall: high (80/100)

Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.

Company profile

address, 1 SIC codes, incorporation date

100

Financials

2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed

Lenders & charges

Confirmed no charges registered

Directors & officers

10 officers (5 active, 10 linked, 10 with DOB)

Ownership & PSC

2 active PSC(s) of 4 total, 4 with control declared

Director network

4 connected companies via shared directors

Filing history

57 filings on record

Gazette notices

No matching gazette notices (standard for active companies)

Opportunity Score

76/100Strong

PassWatchWorth a lookStrongExceptional

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality

Adequate — check latest filings for context.

Acquirability

Strong succession / seller-readiness signals.

Risk profile

Few red flags.

Signal strength

Good data coverage for analysis.

Key financials

2 years extracted from filed iXBRL accounts

Cash

—

Net Worth

—

Current Assets

—

Current Liabilities

—

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · FRS 102

Metric	2024-12-31	2023-12-31
Average employees	900	500

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

2 signals detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days

filings

Last 90 days

filings

• 2 capital
• 2 officers
• 1 confirmation-statement

Last 180 days

filings

• 2 capital
• 2 officers
• 1 confirmation-statement

Counts from Companies House filing history.

Corporate timeline (37 events)Click to expand

2026-03-17
📄
capital-allotment-shares
capital · SH01
2026-03-13
📄
capital-allotment-shares
capital · SH01
2026-03-13
📄
memorandum-articles
incorporation · MA
2026-03-13
📄
resolution
resolution · RESOLUTIONS
2026-03-06
📄
change-person-director-company-with-change-date
officers · CH01
2026-03-04
📄
termination-director-company-with-name-termination-date
officers · TM01
2025-12-31
➖
PORTER, Carolyn, Dr resigned
director
2025-05-07
📄
accounts-with-accounts-type-total-exemption-full
accounts · AA
2025-03-21
📄
change-person-director-company-with-change-date
officers · CH01
2025-03-20
📄
change-person-director-company-with-change-date
officers · CH01
2025-03-20
📄
change-person-director-company-with-change-date
officers · CH01
2024-09-06
📄
accounts-with-accounts-type-total-exemption-full
accounts · AA
2024-05-20
📄
change-person-director-company-with-change-date
officers · CH01
2024-04-04
📄
change-person-director-company-with-change-date
officers · CH01
2024-03-08
📄
capital-allotment-shares
capital · SH01
2024-03-06
📄
resolution
resolution · RESOLUTIONS
2024-02-22
📄
appoint-person-director-company-with-name-date
officers · AP01
2024-02-06
➕
PORTER, Carolyn, Dr appointed
director
2023-12-13
📄
appoint-person-director-company-with-name-date
officers · AP01
2023-12-13
📄
termination-director-company-with-name-termination-date
officers · TM01
2023-11-27
➕
ANNINGA, Bauke, Dr appointed
director
2023-11-27
➖
ZIMBERLIN, Cheryl Doreen resigned
director
2023-09-29
📄
accounts-with-accounts-type-total-exemption-full
accounts · AA
2023-03-16
📄
change-person-director-company-with-change-date
officers · CH01
2023-02-21
📄
termination-director-company-with-name-termination-date
officers · TM01
2022-12-02
➖
HAIGH, Robert Merrick, Dr resigned
director
2022-09-23
➕
JOHNSON, Anthony Gerard appointed
director
2022-09-23
➖
GOKER, Hakan, Dr resigned
director
2022-01-01
➕
HAIGH, Robert Merrick, Dr appointed
director
2021-07-14
➕
ROBERTS, Christopher, Dr appointed
director
2021-04-01
➕
MOORE, Jeffrey Bernard appointed
director
2021-04-01
➕
GOKER, Hakan, Dr appointed
director
2021-04-01
➕
ZIMBERLIN, Cheryl Doreen appointed
director
2020-11-24
➕
VIRDEE, Satpal Singh, Prof appointed
director
2020-11-24
➖
MUIR, Anne Margaret resigned
director
2019-11-26
🏢
Company incorporated
As OUTRUN THERAPEUTICS LIMITED
2019-11-26
➕
MUIR, Anne Margaret appointed
director

Owner dependency

55/100

Moderate — manageable with handover

Some founder dependency, but not acute. A structured handover period should cover most risk.

FACTORS

-5 active directors: Broader management team in place — suggests transferable governance.
+Founder age: Director aged approximately 69 — succession pressure is live.

Succession & seller-readiness

50/100

Moderate signal

Some succession indicators present. Worth watching; approach if sector/strategy fits.

SIGNALS

primaryFounder aged 63+: Senior director is approximately 69. Approaching typical UK retirement age — succession thinking likely.

Red flags

clean

No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Group structure

2 corporate shareholders identified. Group structure is distributed.

🏛️

Merck Kgaa

Corporate parent · holds 25-50% shares

significant stake

🏛️

Mitsubishi Chemical Holdings Corporation

Corporate parent · holds 25-50% shares

significant stake

⬇

OUTRUN THERAPEUTICS LIMITED

This company · SC648164

Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).

Shareholders & ownership

2 active beneficial owners

Name	Shares	Voting rights	Nature of control	Notified
Merck Kgaa Corporate entity	25–50%	25–50%	25-50% shares · 25-50% voting	22/01/2022
Mitsubishi Chemical Holdings Corporation Corporate entity	25–50%	25–50%	25-50% shares · 25-50% voting	22/01/2022

2 historic (ceased) PSCs

Prof Satpal Singh Virdeeceased 22/01/2022· 25-50% shares · 25-50% voting
University Of Dundee (The)ceased 05/03/2021· 75-100% shares · 75-100% voting

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

🔒Co-director network graph

Radial SVG graph showing every company connected via shared directors, colour-coded by status.

Available from the Pro tier upwards.

See pricing →

Similar companies

Active · Healthcare & medical · DD postcode area

Company	Est. value	Turnover	Net worth	Staff	Age	Opp	Director
POSITIVE STEPS INITIATIVES LIMITED→ SC272286 · est 2004	£300.5k £216.4k–£384.7k	—	—	2	21y	83	75y
BALFIELD PROPERTIES LTD→ SC334044 · est 2007	—	—	—	1400	18y	83	66y
THE BRAE RIDING FOR THE DISABLED→ SC205733 · est 2000	—	—	—	7	26y	83	83y
TRANSFORM COMMUNITY DEVELOPMENT→ SC097367 · est 1986	—	—	—	37	40y	83	80y
CAALCARE CARE AND SUPPORT SERVICES LIMITED→ SC300007 · est 2006	—	—	—	1300	20y	82	69y
F.M.S.E. MACFARLANE LIMITED→ SC253335 · est 2003	—	—	—	900	22y	82	80y
ST. DAVID'S CARE (FORFAR) LIMITED→ SC304274 · est 2006	—	—	£734.8k	—	19y	82	65y
CARNOUSTIE, BARRY & PANBRIDE SICK NURSING ASSOCIATION→ SC169926 · est 1996 · no financials extracted	—	—	—	—	29y	81	77y
DEAF LINKS→ SC353562 · est 2009	—	—	—	1400	17y	81	85y
FORFAR DAY CARE CENTRE→ SC239605 · est 2002	—	—	—	1000	23y	81	86y
ICDAS FOUNDATION→ SC305836 · est 2006 · no financials extracted	—	—	—	—	19y	81	77y
TAYSIDE HEALTHCARE ARTS TRUST→ SC307393 · est 2006	—	—	—	100	19y	81	85y

Peers ranked by estimated value, then turnover, then opportunity score.See all →

🔒Tailored diligence questions

7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →

🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive

Typeltd

Incorporated2019-11-26

Jurisdictionscotland

Primary SIC86900 — Other human health activities

Registered office

Errol Road

Invergowrie

Dundee

DD2 5DA

Scotland

Filing status

Accounts

Next due: 2026-09-30

Last made up to: 2024-12-31

Confirmation statement

Next due: 2027-03-26

Last: 2026-03-12

Officers (5 active · 5 resigned)

ANNINGA, Bauke, Dr→

director · ~40y · appointed 2023-11-27

View their other companies + combined net worth →

Active

JOHNSON, Anthony Gerard→

director · ~69y · appointed 2022-09-23

View their other companies + combined net worth →

Active

MOORE, Jeffrey Bernard→

director · ~61y · appointed 2021-04-01

View their other companies + combined net worth →

Active

ROBERTS, Christopher, Dr→

director · ~57y · appointed 2021-07-14

View their other companies + combined net worth →

Active

VIRDEE, Satpal Singh, Prof→

director · ~50y · appointed 2020-11-24

View their other companies + combined net worth →

Active

GOKER, Hakan, Dr→

director · ~51y · appointed 2021-04-01 · resigned 2022-09-23

Resigned

HAIGH, Robert Merrick, Dr→

director · ~66y · appointed 2022-01-01 · resigned 2022-12-02

Resigned

MUIR, Anne Margaret→

director · ~54y · appointed 2019-11-26 · resigned 2020-11-24

Resigned

PORTER, Carolyn, Dr→

director · ~56y · appointed 2024-02-06 · resigned 2025-12-31

Resigned

ZIMBERLIN, Cheryl Doreen→

director · ~40y · appointed 2021-04-01 · resigned 2023-11-27

Resigned

Click a director name to see their full track record across all companies.

Recent filings (57 total)

confirmation-statement-with-updates

confirmation-statement · CS01

2026-04-07

capital-allotment-shares

capital · SH01

2026-03-17

capital-allotment-shares

capital · SH01

2026-03-13

memorandum-articles

incorporation · MA

2026-03-13

resolution

resolution · RESOLUTIONS

2026-03-13

change-person-director-company-with-change-date

officers · CH01

2026-03-06

termination-director-company-with-name-termination-date

officers · TM01

2026-03-04

accounts-with-accounts-type-total-exemption-full

accounts · AA

2025-05-07

change-person-director-company-with-change-date

officers · CH01

2025-03-21

change-person-director-company-with-change-date

officers · CH01

2025-03-20

change-person-director-company-with-change-date

officers · CH01

2025-03-20

confirmation-statement-with-no-updates

confirmation-statement · CS01

2025-03-19

accounts-with-accounts-type-total-exemption-full

accounts · AA

2024-09-06

change-person-director-company-with-change-date

officers · CH01

2024-05-20

change-person-director-company-with-change-date

officers · CH01

2024-04-04